FDA Approves Fospropofol Disodium for Monitored Anaesthesia Care Sedation
Unregistered User
If this is not your name, click here.
Contact Us | Order Now | Journals | Bookstore | Register a colleague
 
  SEARCH  
News
Bookstore
Medline
The Web
Meetings & Congresses
Complete Doctor's Guide
 


 EXPLORE :
 news  All News
 webcasts All Webcasts
 All cases All Cases
 Meetings All Meetings & Congresses
 Medical All Medical Resources

top





New drugs / indications

English Dictionary

Medical Dictionary

Thesaurus



Warning | Privacy | Awards



 Favourite Journals 

Click here to choose your favourite journals


 Favourite Sites 

Click here to choose your favourite sites


 Languages 



  




FDA Approves Fospropofol Disodium for Monitored Anaesthesia Care Sedation

NEW YORK -- December 15, 2008 -- The US Food and Drug Administration (FDA) has approved fospropofol disodium (Lusedra) injection for use as an intravenous sedative-hypnotic agent for sedation in adult patients undergoing diagnostic or therapeutic procedures.

Hypotension was reported in 4% (18/455) patients treated with fospropofol disodium using the standard or modified dosing regimen, and hypoxaemia was reported in 4% (20/455) patients. Apnoea was reported in less than 1% of patients.

Although fospropofol disodium has not been studied for use in general anaesthesia, it has inadvertently caused patients to become unresponsive or minimally responsive to vigorous tactile or painful stimulation. The incidence was 4% (7/183) for colonoscopy and 16% (24/149) for bronchoscopy. The duration of minimal or complete unresponsiveness ranged from 2 to 16 minutes in colonoscopy patients and from 2 to 20 minutes in bronchoscopy patients.

The most common adverse reactions (>20%) are paresthesia and pruritus.

SOURCE: Eisai Corporation of North America

E-mail this page
to a friend or colleague!
To print,
use this version




Any question regarding a medical diagnosis, treatment, referral, drug availability or pricing should be directed to either a licensed physician or to the product's manufacturer.

If you have any technical questions or other concerns about this site, feel free to contact us at webmaster@docguide.com.

All contents Copyright (c) 1995- Doctor's Guide Publishing Limited. All rights reserved.


Employment opportunities | Partnering opportunities